16-20333367-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_003361.4(UMOD):c.1870A>G(p.Lys624Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,612,552 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K624K) has been classified as Likely benign.
Frequency
Consequence
NM_003361.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant medullary cystic kidney disease with or without hyperuricemiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- glomerulocystic kidney disease with hyperuricemia and isosthenuriaInheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
- familial juvenile hyperuricemic nephropathy type 1Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant medullary cystic kidney disease with hyperuricemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.1870A>G | p.Lys624Glu | missense_variant | Exon 11 of 11 | 5 | NM_003361.4 | ENSP00000379442.5 | ||
UMOD | ENST00000396134.6 | c.1969A>G | p.Lys657Glu | missense_variant | Exon 12 of 12 | 2 | ENSP00000379438.2 | |||
UMOD | ENST00000570689.5 | c.1870A>G | p.Lys624Glu | missense_variant | Exon 11 of 11 | 5 | ENSP00000460548.1 | |||
UMOD | ENST00000570331.1 | n.635A>G | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000404 AC: 1AN: 247754 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460418Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726330 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74316 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1870A>G (p.K624E) alteration is located in exon 11 (coding exon 10) of the UMOD gene. This alteration results from a A to G substitution at nucleotide position 1870, causing the lysine (K) at amino acid position 624 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt UMOD protein function. This variant has not been reported in the literature in individuals affected with UMOD-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 624 of the UMOD protein (p.Lys624Glu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at